Paediatric Virology and respiratory syncytial virus: An interview with Honorary Senior Lecturer in Paediatric Infectious Diseases Dr Simon B. Drysdale (St. George's, University of London, UK)

Mammas,Ioannis  N.; Spandidos,Demetrios  A.

doi:10.3892/etm.2019.7947

Paediatric Virology and respiratory syncytial virus: An interview with Honorary Senior Lecturer in Paediatric Infectious Diseases Dr Simon B. Drysdale (St. George's, University of London, UK)

Authors:
- Ioannis N. Mammas
- Demetrios A. Spandidos
View Affiliations

Affiliations: Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece
Published online on: August 28, 2019 https://doi.org/10.3892/etm.2019.7947
Pages: 3226-3230
Copyright: © Mammas et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dr Simon B. Drysdale, Consultant and Honorary Senior Lecturer in Paediatric Infectious Diseases at St. George's University Hospitals NHS Foundation Trust and St. George's, University of London, is one of the most talented early career academic specialists in Paediatric Infectious Diseases in the United Kingdom. His main research interest is respiratory syncytial virus (RSV); he is particularly interested in understanding the host susceptibility to RSV, the management of RSV infection and associated health economics and the development of treatments and immunisations/vaccines, which are currently lacking. According to Dr Drysdale, RSV is a significant cause of morbidity and mortality among young infants and older adults, particularly those with co‑morbidities. While there is ample RSV epidemiological and healthcare cost data available for young infants and children, more data is required for older children and adults. There are currently several antiviral medications for the treatment of RSV infection in development; however, none have yet progressed beyond Phase 2 clinical trials. Multiple types of novel therapeutic molecules have been developed, including fusion and non‑fusion inhibitors and polymerase inhibitors aimed at various RSV targets, such as the F protein and RNA polymerase. In recent years, great strides have been made with regards to an RSV vaccine or monoclonal antibody, with >40 candidates currently in development. A maternal RSV vaccine, which just completed a Phase 3 trial, was shown to have 44% efficacy against hospitalization for RSV lower respiratory tract infection in infants. A new long‑acting monoclonal antibody against RSV infection, having shown excellent promise in a Phase 2 trial in infants, is about to be investigated in a Phase 3 clinical trial commencing shortly.

View Figures

View References

1	Drysdale SB: Diminished lung function, viral infections and chronic respiratory morbidity in prematurely born infants (PhD Thesis)King's College London; London: 2014
2	Sande CJ, Njunge JM, Mwongeli Ngoi J, Mutunga MN, Chege T, Gicheru ET, Gardiner EM, Gwela A, Green CA, Drysdale SB, et al: Airway response to respiratory syncytial virus has incidental antibacterial effects. Nat Commun. 10:22182019. View Article : Google Scholar : PubMed/NCBI
3	Johnstone PD, Jayamohan J, Kelly DF and Drysdale SB: Does appendicitis in a child with a ventriculoperitoneal shunt necessitate shunt revision? Arch Dis Child. 104:607–609. 2019. View Article : Google Scholar : PubMed/NCBI
4	Barr R, McGalliard R and Drysdale SB: Human metapneumovirus in paediatric intensive care unit (PICU) admissions in the United Kingdom (UK) 2006–2014. J Clin Virol. 112:15–19. 2019. View Article : Google Scholar : PubMed/NCBI
5	Lin GL, McGinley JP, Drysdale SB and Pollard AJ: Epidemiology and Immune Pathogenesis of Viral Sepsis. Front Immunol. 9:21472018. View Article : Google Scholar : PubMed/NCBI
6	Drysdale SB and Kelly DF: How to use…respiratory viral studies. Arch Dis Child Educ Pract Ed. Aug 28–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
7	Barr R, Carande EJ, Pollard AJ and Drysdale SB: Change in viral bronchiolitis management in hospitals in the UK after the publication of NICE guideline. J Clin Virol. 105:84–87. 2018. View Article : Google Scholar : PubMed/NCBI
8	MacBean V, Lunt A, Drysdale SB, Yarzi MN, Rafferty GF and Greenough A: Predicting healthcare outcomes in prematurely born infants using cluster analysis. Pediatr Pulmonol. 53:1067–1072. 2018. View Article : Google Scholar : PubMed/NCBI
9	Carande EJ, Galiza EP, Nickless A, Pollard AJ and Drysdale SB: Viral bronchiolitis management in hospitals in the UK. J Clin Virol. 104:29–33. 2018. View Article : Google Scholar : PubMed/NCBI
10	Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, Jarlier V, Nathwani D, Goossens H, Koraqi A, et al Global-PPS network, : Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: Results of an internet-based global point prevalence survey. Lancet Glob Health. 6:e619–e629. 2018. View Article : Google Scholar : PubMed/NCBI
11	Carande EJ, Cheung CR, Pollard AJ and Drysdale SB: Change in viral bronchiolitis management in primary care in the UK after the publication of NICE guideline. Thorax. Jan 9–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
12	MacBean V, Drysdale SB, Yarzi MN, Peacock JL, Rafferty GF and Greenough A: Respiratory viral infections in infancy and school age respiratory outcomes and healthcare costs. Pediatr Pulmonol. 53:342–348. 2018. View Article : Google Scholar : PubMed/NCBI
13	Drysdale SB, Mejias A and Ramilo O: Rhinovirus - not just the common cold. J Infect. 74 (Suppl 1):S41–S46. 2017. View Article : Google Scholar : PubMed/NCBI
14	Robey RC, Drysdale SB, Kelly DF, Bowler IC and Sadarangani M: Age-specific trends in antibiotic resistance in Escherichia coli infections in Oxford, United Kingdom 2013–2014. J Infect. 74:195–198. 2017. View Article : Google Scholar : PubMed/NCBI
15	Drysdale SB and Pollard AJ: Intussusception risk after rotavirus vaccination in England. Vaccine. 34:61142016. View Article : Google Scholar : PubMed/NCBI
16	Carande EJ, Pollard AJ and Drysdale SB: Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases. Can J Infect Dis Med Microbiol. 2016:91395372016. View Article : Google Scholar : PubMed/NCBI
17	Drysdale SB and Kelly DF: Fifteen-minute consultation: Enterovirus meningitis and encephalitis-when can we stop the antibiotics? Arch Dis Child Educ Pract Ed. 102:66–71. 2017. View Article : Google Scholar : PubMed/NCBI
18	Drysdale SB, Alcazar M, Wilson T, Smith M, Zuckerman M, Hodemaekers HM, Janssen R, Bont L, Johnston SL and Greenough A: Functional and genetic predisposition to rhinovirus lower respiratory tract infections in prematurely born infants. Eur J Pediatr. 175:1943–1949. 2016. View Article : Google Scholar : PubMed/NCBI
19	Drysdale SB, Green CA and Sande CJ: Best practice in the prevention and management of paediatric respiratory syncytial virus infection. Ther Adv Infect Dis. 3:63–71. 2016.PubMed/NCBI
20	Versporten A, Bielicki J, Drapier N, Sharland M and Goossens H; ARPEC project group, : The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: Developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother. 71:1106–1117. 2016. View Article : Google Scholar : PubMed/NCBI
21	Drysdale SB, Sande CJ, Green CA and Pollard AJ: RSV vaccine use - the missing data. Expert Rev Vaccines. 15:149–152. 2016. View Article : Google Scholar : PubMed/NCBI
22	Drysdale SB and Pollard AJ: Group B meningococcal vaccine science and policy. J Infect. 71 (Suppl 1):S15–S20. 2015. View Article : Google Scholar : PubMed/NCBI
23	Drysdale SB, Alcazar-Paris M, Wilson T, Smith M, Zuckerman M, Peacock JL, Johnston SL and Greenough A: Viral lower respiratory tract infections and preterm infants' healthcare utilisation. Eur J Pediatr. 174:209–215. 2015. View Article : Google Scholar : PubMed/NCBI
24	Drysdale SB, Lo J, Prendergast M, Alcazar M, Wilson T, Zuckerman M, Smith M, Broughton S, Rafferty GF, Peacock JL, et al: Lung function of preterm infants before and after viral infections. Eur J Pediatr. 173:1497–1504. 2014. View Article : Google Scholar : PubMed/NCBI
25	Drysdale SB, Alcazar M, Wilson T, Smith M, Zuckerman M, Lauinger IL, Tong CY, Broughton S, Rafferty GF, Johnston SL, et al: Respiratory outcome of prematurely born infants following human rhinovirus A and C infections. Eur J Pediatr. 173:913–919. 2014. View Article : Google Scholar : PubMed/NCBI
26	Drysdale SB, Prendergast M, Alcazar M, Wilson T, Smith M, Zuckerman M, Broughton S, Rafferty GF, Johnston SL, Hodemaekers HM, et al: Genetic predisposition of RSV infection-related respiratory morbidity in preterm infants. Eur J Pediatr. 173:905–912. 2014. View Article : Google Scholar : PubMed/NCBI
27	Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V and Goossens H; ARPEC Project Group Members, : The antibiotic resistance and prescribing in European Children project: A neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 32:e242–e253. 2013. View Article : Google Scholar : PubMed/NCBI
28	Drysdale SB, Alcazar-Paris M, Wilson T, Smith M, Zuckerman M, Broughton S, Rafferty GF, Peacock JL, Johnston SL and Greenough A: Rhinovirus infection and healthcare utilisation in prematurely born infants. Eur Respir J. 42:1029–1036. 2013. View Article : Google Scholar : PubMed/NCBI
29	Drysdale SB, Milner AD and Greenough A: Respiratory syncytial virus infection and chronic respiratory morbidity - is there a functional or genetic predisposition? Acta Paediatr. 101:1114–1120. 2012. View Article : Google Scholar : PubMed/NCBI
30	Drysdale SB, Alcazar M, Wilson T, Smith M, Zuckerman M, Wedderburn CJ, Broughton S, Rafferty GF, Johnston SL and Greenough A: Pandemic influenza A (H1N1) virus 2009 in a prospectively followed cohort of prematurely born infants. Pediatr Infect Dis J. 31:91–92. 2012. View Article : Google Scholar : PubMed/NCBI
31	Drysdale SB, Wilson T, Alcazar M, Broughton S, Zuckerman M, Smith M, Rafferty GF, Johnston SL and Greenough A: Lung function prior to viral lower respiratory tract infections in prematurely born infants. Thorax. 66:468–473. 2011. View Article : Google Scholar : PubMed/NCBI
32	Drysdale SB, Coulson T, Cronin N, Manjaly ZR, Piyasena C, North A, Ford-Adams ME and Broughton S: The impact of the National Patient Safety Agency intravenous fluid alert on iatrogenic hyponatraemia in children. Eur J Pediatr. 169:813–817. 2010. View Article : Google Scholar : PubMed/NCBI
33	Newell B, Bedlow AJ, Cliff S, Drysdale SB, Stanton AW and Mortimer PS: Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry. Br J Dermatol. 149:105–110. 2003. View Article : Google Scholar : PubMed/NCBI
34	Stanton AW, Drysdale SB, Patel R, Mellor RH, Duff MJ, Levick JR and Mortimer PS: Expansion of microvascular bed and increased solute flux in human Basal cell carcinoma in vivo, measured by fluorescein video angiography. Cancer Res. 63:3969–3979. 2003.PubMed/NCBI
35	Mammas IN, Theodoridou M and Spandidos DA: The development of the Paediatric Virology Study Group: Ten years in the making. Exp Ther Med. 13:3632017. View Article : Google Scholar : PubMed/NCBI